With TM, CKAP4, IL2, and MMP7 all being able to accurately differentiate between CKD and chronic disease controls, it suggests that there is distinct senescence-specific proteomic regulation within CKD patients which accurately captures this relationship, allowing for clear differentiation. Here, IL2 is linked to chronic kidney disease.